They demonstrated that hydroxynonenal is involved in the pathogenesis of NASH by activating μ-calpain via G-protein coupled receptor 120 (GPR120) and disrupt the lysosomal membrane with the resultant leakage of cathepsin enzymes causing hepatocyte death. The gene discussed is FFAR4; the disease is metabolic dysfunction-associated steatohepatitis.